Correlation of levels and patterns of genomic instability with histological grading of DCIS

Ann Surg Oncol. 2007 Nov;14(11):3070-7. doi: 10.1245/s10434-007-9459-8. Epub 2007 Jun 5.

Abstract

Background: Histological grading of ductal carcinoma-in-situ (DCIS) lesions separates DCIS into three subgroups (well-, moderately, or poorly differentiated). It is unclear, however, whether breast disease progresses along a histological continuum or whether each grade represents a separate disease. In this study, levels and patterns of allelic imbalance (AI) were examined in DCIS lesions to develop molecular models that can distinguish pathological classifications of DCIS.

Methods: Laser microdissected DNA samples were collected from DCIS lesions characterized by a single pathologist including well- (n = 18), moderately (n = 35), and poorly differentiated (n = 47) lesions. A panel of 52 microsatellite markers representing 26 chromosomal regions commonly altered in breast cancer was used to assess patterns of AI.

Results: The overall frequency of AI increased significantly (P < .001) with increasing grade (well differentiated, 12%; moderately differentiated, 17%; poorly differentiated, 26%). Levels of AI were not significantly different between well- and moderately differentiated grades of disease but were significantly higher (P < .0001) in poorly differentiated compared with well- or moderately differentiated disease. No statistically significant differences in patterns of AI were detected between well- and moderately differentiated disease; however, AI occurred significantly more frequently (P < .05) in high-grade lesions at chromosomes 6q25-q27, 8q24, 9p21, 13q14, and 17p13.1, and significantly more frequently in low-grade lesions at chromosome 16q22.3-q24.3.

Conclusions: The inability to discriminate DCIS at the genetic level suggests that grades 1 and 2 DCIS may represent a single, non-high-grade form of DCIS, whereas poorly differentiated DCIS seems to be a genetically more advanced disease that may represent a discrete disease entity, characterized by a unique spectrum of genetic alterations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allelic Imbalance
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / genetics*
  • Carcinoma, Ductal, Breast / diagnosis
  • Carcinoma, Ductal, Breast / genetics*
  • Carcinoma, Intraductal, Noninfiltrating / diagnosis
  • Carcinoma, Intraductal, Noninfiltrating / genetics*
  • Chromosome Aberrations*
  • Chromosome Mapping
  • Chromosomes, Human / ultrastructure*
  • DNA / genetics
  • DNA, Neoplasm / genetics
  • DNA, Neoplasm / metabolism
  • Female
  • Genomic Instability*
  • Humans
  • Middle Aged
  • Prevalence
  • Prognosis

Substances

  • DNA, Neoplasm
  • DNA